Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc.（ENSC）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ENSC · 截至 2026年6月8日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Ensysce Biosciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ENSC 季度内部人买卖趋势
ENSC 内幕交易卖出 · ENSC 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
近期内幕交易记录
ENSC 高管卖出股份 · ENSC 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 2, 2023 | GOWER BOB G Director | Purchase | 90,287 | $44K | Form 4 |
| Mar 1, 2023 | GOWER BOB G Director | Purchase | 270,000 | $129K | Form 4 |
| Feb 28, 2023 | GOWER BOB G Director | Purchase | 109,300 | $53K | Form 4 |
| Dec 9, 2022 | GOWER BOB G Director | Purchase | 357,143 | $500K | Form 4 |
| May 25, 2022 | Kirkpatrick Lynn CEO | Purchase | 27,000 | $14K | Form 4 |
| Jun 30, 2021 | Humphrey David Carl CFO | Award | 50,000 | — | Form 4 |
| Jun 30, 2021 | Chang William H Director | Award | 2,242,189 | — | Form 4 |
| Jun 30, 2021 | Chang William H Director | Award | 353,451 | — | Form 4 |
| Jun 30, 2021 | GOWER BOB G Director | Award | 7,919,026 | — | Form 4 |
| Jun 30, 2021 | Kirkpatrick Lynn CEO · Director | Award | 284,851 | — | Form 4 |
| Jun 19, 2020 | MORGAN STANLEY 10 percent owner | Sale | 776,290 | $8.10M⚡ | Form 4 |
| Dec 1, 2017 | HG Vora Capital Management, LLC 10 percent owner | Purchase | 1,000,000 | $10.00M⚡ | Form 4 |
| Jan 15, 2018 | HG Vora Capital Management, LLC 10 percent owner | Other | 375,000 | — | Form 4 |
| Jan 15, 2018 | WEIL A LORNE Executive Chairman · Director | Other | 132,158 | — | Form 4 |
| Jan 15, 2018 | WEIL A LORNE Executive Chairman · Director | Other | 40,645 | — | Form 4 |
| Jan 15, 2018 | Peng George CFO | Other | 13,251 | — | Form 4 |
| Jan 15, 2018 | Carrera Eric SVP | Other | 8,330 | — | Form 4 |
| Jan 15, 2018 | Silvers Daniel B. CEO · Director | Other | 171,832 | — | Form 4 |
| Dec 5, 2017 | Silvers Daniel B. CEO · Director | Other | 359,869 | — | Form 4 |
| Dec 5, 2017 | WEIL A LORNE Executive Chairman · Director | Other | 169,517 | — | Form 4 |
| Dec 5, 2017 | WEIL A LORNE Executive Chairman · Director | Other | 187,166 | — | Form 4 |
| Dec 5, 2017 | HG Vora Capital Management, LLC 10 percent owner | Other | 718,750 | — | Form 4 |
| Dec 5, 2017 | Carrera Eric SVP | Other | 1,465 | — | Form 4 |
| Dec 5, 2017 | Peng George CFO | Other | 733 | — | Form 4 |
HG Vora Capital Management, LLC
10 percent owner
日期
Dec 1
股数
1,000,000
均价
$10.00
总金额
$10.00M ⚡
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ENSC 内幕交易
ENSC 内幕交易
Ensysce Biosciences, Inc.（ENSC）内幕交易数据来源于公司内部人（包括ENSC）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。ENSC内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Ensysce Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ENSC 内幕交易 · 5个问题Ensysce Biosciences, Inc.（ENSC）的内部人包括高管和董事，如ENSC等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026